Thomas K. Baker
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Hepatology top 10%
- Liver physiology and pathology
Papers in
-
- Gene expression and cancer classification 3
- Connexins and lens biology 3
-
- Toxic Organic Pollutants Impact 3
- Co-authors
- James Stevens (4 shared papers)James E. Klaunig (6 shared papers)George H. Searfoss (4 shared papers)Hong Gao (3 shared papers)Timothy P. Ryan (3 shared papers)Mark A. Carfagna (2 shared papers)A Kwiatkowski (2 shared papers)Qingqin S. Li (1 shared paper)
- Journals
- Toxicological Sciences (4 papers)Toxicology Letters (3 papers)Weed Technology (3 papers)Carcinogenesis (2 papers)Drug Discovery Today (2 papers)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Thomas K. Baker
27 papers receiving 799 citations
Peers
Comparison fields: 5 of 99
- Pharmacology 121
- Hepatology 72
- Health, Toxicology and Mutagenesis 95
- Cancer Research 83
- Computational Theory and Mathematics 91
Countries citing papers authored by Thomas K. Baker
This map shows the geographic impact of Thomas K. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas K. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas K. Baker more than expected).
Fields of papers citing papers by Thomas K. Baker
This network shows the impact of papers produced by Thomas K. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas K. Baker. The network helps show where Thomas K. Baker may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas K. Baker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 211 | |
| 2 | 2001 | 118 | |
| 3 | 1995 | 50 | |
| 4 | 2003 | 48 | |
| 5 | 1995 | 42 | |
| 6 | 2012 | 42 | |
| 7 | 2020 | 32 | |
| 8 | 2007 | 31 | |
| 9 | 2003 | 30 | |
| 10 | 1990 | 27 | |
| 11 | 2010 | 26 | |
| 12 | 1994 | 25 | |
| 13 | 2021 | 21 | |
| 14 | 2006 | 20 | |
| 15 | 2013 | 17 | |
| 16 | 2021 | 17 | |
| 17 | 2016 | 17 | |
| 18 | Modulation of gap junctional intercellular communication in rodent, monkey and human hepatocyte by nongenotoxic compounds. | 1995 | 15 |
| 19 | 2023 | 11 | |
| 20 | 1990 | 8 |
About Thomas K. Baker
Thomas K. Baker is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis, Oncology, Computational Theory and Mathematics and Immunology, having authored 28 papers that have together received 835 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (4 papers), Gene expression and cancer classification (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Connexins and lens biology (3 papers), Toxic Organic Pollutants Impact (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Adipose Tissue and Metabolism (2 papers). The work is most often cited by research in Pharmacology (121 citations), Hepatology (72 citations), Health, Toxicology and Mutagenesis (95 citations), Cancer Research (83 citations) and Computational Theory and Mathematics (91 citations). Thomas K. Baker has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include James Stevens, James E. Klaunig, George H. Searfoss, Hong Gao, Timothy P. Ryan, Mark A. Carfagna, A Kwiatkowski, Qingqin S. Li, Ernst R. Dow and Thomas F. Peeper. Their work appears in journals such as Toxicological Sciences, Toxicology Letters, Weed Technology, Carcinogenesis and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.